{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:17Z","timestamp":1761178577100,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.018","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T07:49:38Z","timestamp":1661327378000},"page":"921-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enjeux et limites de la d\u00e9sescalade th\u00e9rapeutique dans la prise en charge du cancer de l\u2019oropharynx li\u00e9 au papillomavirus"],"prefix":"10.1016","volume":"26","author":[{"given":"A.","family":"Modesto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Graff Cailleaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Boisselier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.018_bib0155","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0160","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y","article-title":"Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16\u00a0with squamous cell carcinoma of Waldeyer's tonsillar ring","volume":"79","author":"Paz","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2022.06.018_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.canrad.2022.06.018_bib0175","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129\u00a0trial: long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0180","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2022.06.018_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000318","article-title":"Establishment of human papillomavirus infection requires cell cycle progression","volume":"5","author":"Pyeon","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.canrad.2022.06.018_bib0195","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/lary.23516","article-title":"Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis","volume":"122","author":"Laborde","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2022.06.018_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1440-1827.2002.01359.x","article-title":"Overexpression of p16\u00a0and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia","volume":"52","author":"Sano","year":"2002","journal-title":"Pathol Int"},{"key":"10.1016\/j.canrad.2022.06.018_bib0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0210","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0215","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2009.03.004","article-title":"Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT","volume":"74","author":"Gupta","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.018_bib0220","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9","article-title":"Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma","volume":"92","author":"Lindel","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2022.06.018_bib0225","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/annonc\/mdu004","article-title":"Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis","volume":"25","author":"Bossi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00066-019-01451-8","article-title":"Definitive radiochemotherapy or initial surgery for oropharyngeal cancer: To what extent can p16\u00a0expression be used in the decision process?","volume":"195","author":"Modesto","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0235","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ejso.2020.12.011","article-title":"Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study","volume":"47","author":"Culie","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0240","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the orator trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0245","article-title":"Assessment of Toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the orator2\u00a0phase 2\u00a0randomized clinical trial","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0250","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/lary.27544","article-title":"Cost comparison of treatment for oropharyngeal carcinoma","volume":"129","author":"Tam","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2022.06.018_bib0255","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.73.8.6209-6219.1999","article-title":"The human papillomavirus type 16\u00a0E6\u00a0oncoprotein can down-regulate p53\u00a0activity by targeting the transcriptional coactivator CBP\/p300","volume":"73","author":"Zimmermann","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0260","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ctrv.2015.10.001","article-title":"Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives","volume":"41","author":"Mirghani","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2022.06.018_bib0265","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0270","unstructured":"www.clinicalTrials.gov Identifier: NCT03952585."},{"key":"10.1016\/j.canrad.2022.06.018_bib0275","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.06.018_bib0280","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.018_bib0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3\u00a0trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.06.018_bib0290","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk hpv-associated oropharyngeal cancer (TROG 12.01) - a trans-tasman radiation oncology group study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.018_bib0295","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1\u00a0pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2022.06.018_bib0150","unstructured":"www.clinicalTrials.gov Identifier: NCT03383094."}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:22Z","timestamp":1761136522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001202"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.018","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enjeux et limites de la d\u00e9sescalade th\u00e9rapeutique dans la prise en charge du cancer de l\u2019oropharynx li\u00e9 au papillomavirus","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}